{"id":"https://openalex.org/W981764576","doi":null,"title":"Hiperprolactinemia en pacientes esquizofr\u00e9nicos en tratamiento con antipsic\u00f3ticos","display_name":"Hiperprolactinemia en pacientes esquizofr\u00e9nicos en tratamiento con antipsic\u00f3ticos","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W981764576","mag":"981764576"},"language":"es","primary_location":{"id":"mag:981764576","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=3032767","pdf_url":null,"source":{"id":"https://openalex.org/S4306401293","display_name":"Dialnet (Universidad de la Rioja)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I168974976","host_organization_name":"Universidad de La Rioja","host_organization_lineage":["https://openalex.org/I168974976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027544000","display_name":"Emilio Gonz\u00e1lez Pablos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilio Gonz\u00e1lez Pablos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Francisco Javier Garc\u00eda S\u00e1nchez","orcid":"https://orcid.org/0000-0002-8591-9950","observed_orcids":["https://orcid.org/0000-0002-8591-9950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francisco Javier Garc\u00eda S\u00e1nchez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8591-9950","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Consuelo Pascual","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Consuelo Pascual","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103882951","display_name":"Guillermo Hoyos Villagr\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Hoyos Villagr\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080852006","display_name":"Ignacio Herreros Guilarte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Herreros Gilarte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030650157","display_name":"Ricardo Gallardo Ponce","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Gallardo Ponce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104366299","display_name":"F. Primo Herrero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Primo Herrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111393125","display_name":"C. Botillo Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Botillo Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051947721","display_name":"Aguilar-Henr\u00edquez Andr\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aguilar-Henr\u00edquez Andr\u00e9s","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111393124","display_name":"L. Minguez Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Minguez Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07693991,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"2","first_page":"79","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13397","display_name":"Hallucinations in medical conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8270000219345093},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.824999988079071},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7900000214576721},{"id":"https://openalex.org/keywords/serum-prolactin-levels","display_name":"serum prolactin levels","score":0.7889999747276306},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8958152532577515},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6749842762947083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6474097371101379},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6418969035148621},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.625730037689209},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.553317666053772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5425087213516235},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.5107021927833557},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.4636214077472687},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.4390806555747986},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43077534437179565},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4030146896839142},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39995330572128296},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30826303362846375},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.09735462069511414}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:981764576","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=3032767","pdf_url":null,"source":{"id":"https://openalex.org/S4306401293","display_name":"Dialnet (Universidad de la Rioja)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I168974976","host_organization_name":"Universidad de La Rioja","host_organization_lineage":["https://openalex.org/I168974976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2029716422","https://openalex.org/W1799131680","https://openalex.org/W177311148","https://openalex.org/W1975183019","https://openalex.org/W4387383812","https://openalex.org/W2108752633","https://openalex.org/W7117942544","https://openalex.org/W4401920450","https://openalex.org/W2041281069","https://openalex.org/W1916036599"],"abstract_inverted_index":{"Introduction:":[0],"High":[1],"prolactine":[2,209],"serum":[3,72,210],"level":[4,129],"is":[5],"an":[6],"adverse":[7],"effect":[8],"due":[9],"to":[10,34,167],"narcoleptic":[11],"treatment.":[12],"More":[13],"frequently":[14],"produced":[15],"by":[16],"typical":[17,154,158,220],"antipsychotics":[18,99,105,113,151,155,161],"than":[19,201,218],"atypical":[20,112,160,215],"ones.":[21],"Aim:":[22],"To":[23],"find":[24],"out":[25],"the":[26,35,144,148,172,196,227],"prevalence":[27],"of":[28,37,49,58,67,130,132,138,195],"hyperprolactinemia":[29,139,174],"in":[30,94,185,212],"our":[31],"patients":[32,46,197,213],"related":[33],"type":[36],"antipsychotic":[38,169,216,221],"drug":[39,170],"used.":[40],"Sample:":[41],"Two":[42],"hundred":[43],"and":[44,62,111,159,190,224],"forty":[45],"diagnosed,":[47],"mainly,":[48],"schizophrenia":[50],"following":[51,173],"ICD-10":[52],"criteria,":[53],"with":[54,121,127],"a":[55,63,128],"mean":[56,64],"age":[57],"60.42":[59],"years":[60],"old":[61],"hospital":[65],"stay":[66],"18.20":[68],"years.":[69],"Method:":[70],"Prolactine":[71],"levels":[73,211],"were":[74,147],"determined":[75],"(normal":[76],"values:":[77],"1.5-25":[78],"ng/ml":[79,86],"for":[80,87,143],"women":[81],"on":[82,214,219],"fertile":[83],"age,":[84],"0.7-20":[85],"post-menopause":[88],"women).":[89],"The":[90],"sample":[91],"was":[92,119,140],"divided":[93],"three":[95],"groups:":[96],"-":[97,103,109],"Typical":[98,110],"group:":[100,106,114,152,156,162],"44":[101],"patients.":[102,108,116],"Atypical":[104,150],"126":[107],"57":[115],"Statistical":[117,164],"analysis":[118,126,165],"performed":[120],"SPSS":[122],"v.15.0,":[123],"using":[124],"correlation":[125],"significance":[131],"p":[133],"<":[134],"0.05.":[135],"Results:":[136],"Prevalence":[137],"69.5%.":[141],"Results":[142],"different":[145],"groups":[146],"following:":[149],"64.3%;":[153],"70.5;":[157],"80.4.":[163],"according":[166],"concrete":[168],"showed":[171,198],"percentages:":[175],"risperidone:":[176],"91.5%;":[177],"haloperidol:":[178],"73.3,":[179],"clozapine:":[180],"7,7.":[181],"Hyperprolactinemia":[182],"usually":[183],"fluctuated":[184],"moderate":[186],"values":[187,200],"(between":[188],"25":[189],"99":[191],"ng/ml),":[192],"but":[193],"20%":[194],"higher":[199],"100":[202],"ng/ml.":[203],"Conclusions:":[204],"Our":[205],"study":[206],"finds":[207],"lower":[208],"treatment":[217],"one.":[222],"Haloperidol":[223],"risperidone":[225],"got":[226],"highest":[228],"levels.":[229]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}